Stock Watch: Gene Therapy’s Bittersweet Approvals
Two FDA Approvals Could Herald Two Different Financial Outcomes
There are instances where the FDA approval of an unpartnered drug is the worst outcome for a biotech company. We may have just seen the first such gene therapy example.
